ReShape Lifesciences Inc (RSLS NASDAQ) stock market data APIs
$2.8958
-0.46(-15.9%)
as of June 16, 2025
Try our APIs with
free plan!
ReShape Lifesciences Inc Financial Data Overview
ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System to treat obesity and invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is involved in the development of the ReShape Obalon Balloon System, which consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and the Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in Irvine, California.
Prev. Close
2.8958
Open
2.4378
High
2.8958
Low
2.411
52 wk Range
2.23-414.7
Market Cap
3 355 K
P/E Ratio
0.0095
Shares Outstanding
1 331 K
Revenue
7 175 K
EPS
-2.4124
Beta
1.939
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ReShape Lifesciences Inc data using free add-ons & libraries
Get ReShape Lifesciences Inc Fundamental Data
ReShape Lifesciences Inc Fundamental data includes:
- Net Revenue: 7 175 K
- EBITDA: -6 277 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ReShape Lifesciences Inc News
New
ReShape Signs Exclusive Deal With Recon Supply To Distribute Devices Across VA And DoD Systems
(RTTNews) - ReShape Lifesciences Inc. (RSLS), on Thursday announced it has entered into an exclusive U.S. distribution agreement with Recon Supply to expand access to its medical device portfolio acro...
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
IRVINE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of ...
ReShape Lifesciences prices $2.6M public offering
* ReShape Lifesciences (NASDAQ:RSLS [https://seekingalpha.com/symbol/RSLS]) on Monday announced the pricing of its public offering of 1.05M shares of common stock at a public offering price of $2.50...
ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
IRVINE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Qualit...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
